CAGRILINTIDE 10MG

RESEARCH PEPTIDE

CAGRILINTIDE

LONG-ACTING AMYLIN ANALOG METABOLIC RESEARCH COMPOUND

CAGRILINTIDE IS A LONG-ACTING SYNTHETIC ANALOG OF AMYLIN, A PANCREATIC PEPTIDE CO-SECRETED WITH INSULIN THAT PLAYS A ROLE IN POSTPRANDIAL GLUCOSE REGULATION, GASTRIC EMPTYING, AND SATIETY SIGNALING. IT HAS BEEN STUDIED IN PRECLINICAL AND CLINICAL MODELS AS A TOOL FOR INVESTIGATING AMYLIN RECEPTOR PATHWAYS AND THEIR CONTRIBUTION TO ENERGY HOMEOSTASIS. ITS EXTENDED HALF-LIFE COMPARED TO NATIVE AMYLIN MAKES IT A PRACTICAL COMPOUND FOR LONGITUDINAL METABOLIC RESEARCH.

PUBLISHED RESEARCH HAS EXPLORED CAGRILINTIDE IN COMBINATION STUDIES ALONGSIDE GLP-1 RECEPTOR AGONISTS, EXAMINING ADDITIVE AND SYNERGISTIC EFFECTS ON APPETITE SIGNALING AND BODY COMPOSITION MODELS. SCIENTISTS STUDYING NEUROENDOCRINE REGULATION OF FEEDING BEHAVIOR, PANCREATIC PEPTIDE BIOLOGY, AND OBESITY RESEARCH HAVE UTILIZED THIS COMPOUND IN CONTROLLED LABORATORY ENVIRONMENTS. IT REPRESENTS A KEY RESEARCH TOOL IN THE EVOLVING FIELD OF MULTI-HORMONE METABOLIC SIGNALING.

⚠ LEGAL DISCLAIMER — FOR RESEARCH USE ONLY

THIS PRODUCT IS INTENDED STRICTLY FOR RESEARCH PURPOSES ONLY. IT IS NOT INTENDED FOR HUMAN CONSUMPTION, VETERINARY USE, OR ANY OTHER USE. THIS PRODUCT HAS NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION (FDA). IT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE OR MEDICAL CONDITION. FOR USE BY LICENSED RESEARCH PROFESSIONALS ONLY.